MG
WST icon

Michael Gelband’s West Pharmaceutical WST Stock Holding History

Michael Gelband’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
30,860
+4,046
+15% +$1.24M 0.07% 267
2026
Q1 		$6.72M Buy
26,814
+10,246
+62% +$2.55M 0.05% 346
2025
Q4 		$4.56M Buy
+16,568
New +$4.53M 0.04% 498
2025
Q1 		– Sell
-57,725
Closed -$18.9M – 2068
2024
Q4 		$18.9M Buy
+57,725
New +$18.2M 0.13% 135
2024
Q3 		– Sell
-48,945
Closed -$16.1M – 2152
2024
Q2 		$16.1M Buy
48,945
+17,034
+53% +$6.02M 0.11% 160
2024
Q1 		$12.6M Buy
+31,911
New +$11.8M 0.1% 177
2023
Q4 		– Sell
-5,001
Closed -$1.88M – 2114
2023
Q3 		$1.88M Sell
5,001
-25,384
-84% -$9.82M 0.02% 696
2023
Q2 		$11.6M Buy
+30,385
New +$10.9M 0.09% 218
2022
Q4 		– Sell
-17,220
Closed -$4.24M – 2198
2022
Q3 		$4.24M Buy
+17,220
New +$5.25M 0.06% 464
2021
Q4 		– Sell
-3,675
Closed -$1.56M – 2651
2021
Q3 		$1.56M Buy
3,675
+1,865
+103% +$786K 0.02% 831
2021
Q2 		$650K Buy
+1,810
New +$598K 0.01% 1224
2021
Q1 		– Sell
-2,306
Closed -$653K – 2673
2020
Q4 		$653K Sell
2,306
-1,625
-41% -$456K 0.01% 1088
2020
Q3 		$1.08M Buy
+3,931
New +$1.04M 0.02% 653
2019
Q4 		– Sell
-175,166
Closed -$24.8M – 1927
2019
Q3 		$24.8M Buy
175,166
+161,322
+1,165% +$22.2M 0.87% 16
2019
Q2 		$1.73M Buy
+13,844
New +$1.63M 0.07% 172

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Michael Gelband's WST Position: Q2 2026 in Review

Michael Gelband increased its West Pharmaceutical (WST) stake by 15% in Q2 2026, buying an estimated $1.24M and bringing the position to 30,860 shares worth $11.1M. The position accounts for 0.07% of the portfolio, ranked #267.

Michael Gelband first reported a position in WST in Q2 2019 and has held it in 15 quarters since. The position peaked at $24.8M in Q3 2019. 827 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Michael Gelband held 30,860 shares of West Pharmaceutical worth $11.1M as of Q2 2026.
  • Michael Gelband bought 4,046 West Pharmaceutical shares in Q2 2026, an estimated $1.24M.
  • West Pharmaceutical made up 0.07% of Michael Gelband's portfolio in Q2 2026, its #267 holding.
  • Michael Gelband first reported a position in West Pharmaceutical in Q2 2019 and has held it in 15 quarters since.
  • Michael Gelband's West Pharmaceutical position peaked at $24.8M in Q3 2019.
  • 827 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.